About: Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2010 (fr) наукова стаття, опублікована в січні 2011 (uk) im Januar 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2010 (ast) scientific article published on 01 October 2010 (en)
publication date	wds:Q57185352-C33EF8E3-4374-468D-83FE-8B60D521BF45
publication date	2010-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57185352-44C22B6E-7E03-4C0F-A52F-3E820B2D004B
language of work or name	English
cites work	wds:Q57185352-29CCB04D-E960-4F16-A5A5-BF7678014866
cites work	Strategies for silencing human disease using RNA interference
author name string	wds:Q57185352-0154D648-CBA3-429D-BE84-F2EA95699C0B wds:Q57185352-0DAF92CA-BC67-490B-9C49-C18C68CFB797 wds:Q57185352-19F47599-250B-4EF9-824C-8325FAB41192 wds:Q57185352-2389D9AC-81CF-4B4E-A9F1-C912039EE053 wds:Q57185352-6960BDD5-AC39-4054-B4F0-23A59A8D4485 wds:Q57185352-782B6207-0D31-4DC4-8253-6E356F5AD8A9
author name string	Jimmy D Bell Andrew D Miller Elham Shamsaei Gavin D Kenny Leigh P Brody Meliz Sahuri
rdfs:label	Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (en) Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (nl)
skos:prefLabel	Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (en) Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (nl)
name	Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (en) Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (nl)
author	wds:Q57185352-4C860907-69B5-45EF-BCA2-8150FC9346C7 wds:Q57185352-B476BF0A-70E0-4F29-A37B-669651AF1F45
author	Nazila Kamaly Tammy Kalber
title	wds:Q57185352-AF2D328F-E4EF-4FAF-BC62-9017579E6B92
title	Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo (en)
page(s)	wds:Q57185352-9DA18C5C-74D5-49D5-BF74-426C68BFF562
page(s)	111-116
instance of	wds:Q57185352-1560619B-7A61-4816-B680-3A0259E0979C
instance of	scholarly article
main subject	wds:Q57185352-AE0FC6E7-0FCF-4FA3-8EEF-BCC47B78C46B
main subject	nanoparticle
PubMed ID	wds:Q57185352-C0EA2343-B349-4A74-86B2-D09F6B0DFE0A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20888381
PubMed ID	20888381
published in	wds:Q57185352-8D485FB7-60F9-42BC-9ED9-71B3BE80DD50
published in	Journal of Controlled Release
issue	wds:Q57185352-E19C853D-018D-4465-92E3-446B4E2702FB
volume	wds:Q57185352-28130972-B325-4D4A-9279-E68CF5575CD9
issue	2
volume	149
DOI	wds:Q57185352-80094976-713D-4A84-8D4D-0A42F57FC203
DOI	http://dx.doi.org/10.1016/J.JCONREL.2010.09.020
DOI	10.1016/J.JCONREL.2010.09.020
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57185352
is cites work of	Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting Optimizing tumor targeting of the lipophilic EGFR-binding radiotracer SKI 243 using a liposomal nanoparticle delivery system Advance of molecular imaging technology and targeted imaging agent in imaging and therapy Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles PSMA-targeted theranostic nanoplex for prostate cancer therapy. Post-coupling strategy enables true receptor-targeted nanoparticles. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon Targeted nanotechnology for cancer imaging Nanotechnology for energy-based cancer therapies Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging Theranostic nanoparticles for cancer and cardiovascular applications In vivo imaging of the systemic delivery of small interfering RNA. Multimodality imaging of RNA interference Liposomes in drug delivery: a patent review (2007 - present). Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking Delivery of RNAi therapeutics: work in progress Nanomedicines for renal disease: current status and future applications Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate. Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems Theranostic Nanomedicine for Malignant Gliomas Advances in siRNA delivery in cancer therapy Targeted nanotheranostics for personalized cancer therapy. Lipid-based nanoparticles in cancer diagnosis and therapy Nanotechnology based platforms for survivin targeted drug discovery Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA. Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke Delivering the promise of small ncRNA therapeutics Nanomedicine therapeutics and diagnostics are the goal Oligonucleotide-based theranostic nanoparticles in cancer therapy Innovative approaches for cancer treatment: current perspectives and new challenges Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects Cationic Lipid-Based Nucleic Acid Vectors.
is cites work of	wds:Q38193333-AAB1AAF9-37F3-4770-9D52-F3FCA2A91F29 wds:Q38112726-82B67044-BECD-435E-A867-51EA75B8EAC7 wds:Q36777292-48E2FBD0-E67A-4362-A0E4-846F059BD120 wds:Q38160246-79D6CFED-1DE9-449D-8934-325C5ECF44DC wds:Q52880767-2FA7AFD0-50F5-494E-862C-69E3B2D11FFF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software